Clinical Trial Update: Losartan and Inflammation in Cystic Fibrosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating losartan for inflammation in cystic fibrosis; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Losartan (losartan)

Snippet

Sponsor: University of Miami | Conditions: Cystic Fibrosis | Phase 2 | Status: TERMINATED | Results posted: 2020-11-13